Order Article Reprints

Bennebroek CAM, van Zwol J, Porro GL, Oostenbrink R, Dittrich ATM, Groot ALW, Pott JW, Janssen EJM, Bauer NJ, van Genderen MM, et al. Impact of Bevacizumab on Visual Function, Tumor Size, and Toxicity in Pediatric Progressive Optic Pathway Glioma: A Retrospective Nationwide Multicentre Study. Cancers. 2022; 14(24):6087. https://doi.org/10.3390/cancers14246087

Bennebroek, Carlien A. M., Judith van Zwol, Giorgio L. Porro, Rianne Oostenbrink, Anne T. M. Dittrich, Annabel L. W. Groot, Jan W. Pott, Etienne J. M. Janssen, Noël J. Bauer, Maria M. van Genderen, and et al. 2022. "Impact of Bevacizumab on Visual Function, Tumor Size, and Toxicity in Pediatric Progressive Optic Pathway Glioma: A Retrospective Nationwide Multicentre Study" Cancers 14, no. 24: 6087. https://doi.org/10.3390/cancers14246087

Bennebroek, C. A. M., van Zwol, J., Porro, G. L., Oostenbrink, R., Dittrich, A. T. M., Groot, A. L. W., Pott, J. W., Janssen, E. J. M., Bauer, N. J., van Genderen, M. M., Saeed, P., Lequin, M. H., de Graaf, P., & Schouten-van Meeteren, A. Y. N. (2022). Impact of Bevacizumab on Visual Function, Tumor Size, and Toxicity in Pediatric Progressive Optic Pathway Glioma: A Retrospective Nationwide Multicentre Study. Cancers, 14(24), 6087. https://doi.org/10.3390/cancers14246087